Sort
40,608 grants matching “prostate cancer”
PRECLINICAL ASSESSMENT OF BMX/ETK INHIBITORS FOR PROSTATE CANCER
$637,500Beth Israel Deaconess Medical Center, Inc. · · FY2009 · Department of the Army
Robot-assisted catheter placement with novel shape-sensing stylet to facilitate adaptive image guided pelvic brachytherapy
$637,461Junichi Tokuda · Brigham And Women'S Hospital · R01 · FY2025 · EB
Fine-mapping of 8q24 and Loci Identified in Genome-Wide Studies for Breast & Colo
$637,181Christopher Alan Haiman · University Of Southern California · R01 · FY2010 · CA
The role of tumor-macrophage hybrid cells in prostate cancer metastasis
$637,168Tim H.-M. Huang · University Of Texas Hlth Science Center · U01 · FY2024 · CA
The role of tumor-macrophage hybrid cells in prostate cancer metastasis
$637,168Tim H.-M. Huang · University Of Texas Hlth Science Center · U01 · FY2025 · CA
"Novel Mouse Models for Quantitative Understanding of Baseline and Therapy-Driven Evolution of Prostate Cancer Metastasis"
$637,090Dawid Grzegorz Nowak · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Genomic and Translational Approaches to Neuroendocrine Switching Events
$637,022Michael G Rosenfeld · University Of California, San Diego · R37 · FY2012 · DK
Development of large-field-of-view hyperpolarized MRI
$637,022Kayvan R Keshari · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
MECHANISM OF HORMONE INDEPENDENCE AND DRUG RESISTANCE IN PROSTATE CANCER
$636,935Dana-Farber Cancer Institute, Inc. · · FY2015 · Department of the Army
Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility
$636,877Ross Lake · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
Clinical genomic predictive model of first line androgen receptor inhibitor therapy outcomes in men with mCRPC
$636,857Susan Halabi · Duke University · R01 · FY2023 · CA
Focal Laser Ablation of Prostate Cancer using MR/US Fusion
$636,840Leonard Stephen Marks · University Of California Los Angeles · R01 · FY2018 · CA
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer
$636,821Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Prostate Cancer Imaging
$636,801Peter L. Choyke · Basic Sciences · Z01 · FY2007 · CA
MR Fingerprinting and Computerized Decision Support for Prostate Cancer
$636,773Vikas Gulani · Case Western Reserve University · R01 · FY2018 · CA
Translational Pathology Core
$636,643Peter A Jones · University Of Southern California · P30 · FY2015 · CA
Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)
$636,578Ana Aparicio · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)
$636,578Ana Aparicio · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Molecular Biomarkers of Long-Term Response to Androgen Deprivation Therapy and Radiation in Prostate Cancer
$636,570Christopher A Maher · Washington University · R01 · FY2023 · CA
ICON TARGETING OF TUMOR VASCULATURE AND TUMOR CELLS
$636,541Albert B Deisseroth · University Of California, San Diego · P01 · FY2009 · CA
A Statistical Physics Framework for Understanding the Role of Repeat RNA in Tumor Immunity
$636,517Benjamin Greenbaum · Sloan-Kettering Inst Can Research · U01 · FY2023 · CA
A Statistical Physics Framework for Understanding the Role of Repeat RNA in Tumor Immunity
$636,517Benjamin Greenbaum · Sloan-Kettering Inst Can Research · U01 · FY2022 · CA
Nutrition, Metabolism, and Cancer
$636,512Regina G Ziegler · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
$636,508Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
$636,508Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA